Eur Rev Med Pharmacol Sci 2019; 23 (11): 4763-4769
DOI: 10.26355/eurrev_201906_18058

MiRNA-93-5p promotes the biological progression of gastric cancer cells via Hippo signaling pathway

H. Meng, Y.-Y. Li, D. Han, C.-Y. Zhang

Department of Gastroenterology, Shanxian Central Hospital of Shangdong Province (The Huxi Affiliated Hospital of Jining Medical College), Shanxian County, China. zhangchunyan210@126.com


OBJECTIVE: To clarify the influence of microRNA-93-5p (miRNA-93-5p) on biological behaviors of gastric cancer (GC) cells and its regulatory effect on Hippo pathway.

MATERIALS AND METHODS: SGC-7901 and HGC-27 cells were used for establishing miRNA-93-5p overexpression and downregulation model through transfection of miRNA-93-5p mimics or inhibitor, respectively. Relative levels of genes in Hippo pathway were determined in GC cells transfected with miRNA-93-5p mimics or inhibitor by quantitative Real-time polymerase chain reaction (qRT-PCR). Regulatory effects of miRNA-93-5p on proliferative, migratory and invasive abilities of GC cells were evaluated by cell counting kit-8 (CCK-8), colony formation and transwell assay, respectively.

RESULTS: MiRNA-93-5p was markedly upregulated by transfection of miRNA-93-5p mimics into SGC-7901 cells, which was downregulated by transfection of miRNA-93-5p inhibitor into HGC-27 cells. Overexpression of miRNA-93-5p accelerated GC cells to proliferate, migrate and invade. Meanwhile, miRNA-93-5p overexpression in GC cells upregulated downstream genes in Hippo pathway, including CDX2, FOXM1 and CTGF.

CONCLUSIONS: MiRNA-93-5p enhances proliferative, migratory and invasive abilities of GC cells by activating Hippo pathway, which may serve as a diagnostic and therapeutic target for GC.

Free PDF Download

To cite this article

H. Meng, Y.-Y. Li, D. Han, C.-Y. Zhang
MiRNA-93-5p promotes the biological progression of gastric cancer cells via Hippo signaling pathway

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 11
Pages: 4763-4769
DOI: 10.26355/eurrev_201906_18058